A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
Active, not recruiting · NCT05395533 · Registry updated 2025-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL. | CD20-positive B-cell Non-Hodgkin Lymphoma | Active, not recruiting | Phase 1 | 2025-06-25 | NCT05395533 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Teruisi Pharmaceutical Inc. | 3 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Sciences, Cancer Hospital | Beijing | China | 3 |
| Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University) | Zhengzhou | China | 1 |
| Second Affiliated Hospital of Soochow University | Suzhou | China | 1 |
| Sun Yat-sen University Cancer Center (SYSUCC) | Guangzhou | China | 2 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 56 |
| Tianjin Medical University Cancer Institute & Hospital (TMUCIH) | Tianjin | China | 1 |